The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
Hansen HH, Ebbesen C, Mathiesen C, Weikop P, Rønn LC, Waroux O, Scuvée-Moreau J, Seutin V, Mikkelsen JD. J Pharmacol Exp Ther. 2006 Sep; 318(3):1006-19. Epub 2006 Jun 14.